Comments
Loading...
Latest Repligen Stock News | NASDAQ:RGEN | Benzinga
Get the latest news on Repligen stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Repligen performance
Categories: All
Tuesday, March 18, 2025
Tuesday, March 04, 2025
Friday, February 21, 2025
Thursday, February 20, 2025
- Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
- Repligen shares are trading higher after the ...
- Repligen Sees FY2025 GAAP EPS $0.90-$0.99 Vs,...
- Repligen Sees FY2025 Adj EPS $1.67-$1.76 vs $...
- Repligen Q4 2024 Adj EPS $0.44 Beats $0.41 Es...
- Earnings Scheduled For February 20, 2025
Thursday, January 23, 2025
Monday, January 06, 2025
Tuesday, December 17, 2024
Thursday, November 14, 2024
Tuesday, November 12, 2024
- Repligen Q3 Earnings Beat Expectations, Highlights Improving Market Conditions, Analyst Says Well-Positioned For Long-Term Growth
- 10 Health Care Stocks Whale Activity In Today's Session
- Repligen Raises FY24 Adj EPS Guidance from $1...
- Repligen Raises FY24 GAAP EPS Guidance from $...
- Repligen shares are trading higher after the ...
- Repligen Q3 2024 Adj. EPS $0.43 Beats $0.33 E...
- Earnings Scheduled For November 12, 2024
Thursday, September 26, 2024
Wednesday, September 18, 2024
Tuesday, August 27, 2024
Friday, August 16, 2024
Monday, August 05, 2024
Wednesday, July 31, 2024
Tuesday, July 30, 2024
- Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Repligen Lowers Guidance On China Weakness, Analyst Expects
- Stephens & Co. Reiterates Overweight on Repli...
- PayPal Posts Upbeat Earnings, Joins Sprouts Farmers Market, Stanley Black & Decker, Phillips 66 And Other Big Stocks Moving Higher On Tuesday
- Repligen shares are trading higher. The compa...
- Repligen Expects 2024 Revenues Of $620M-$635M...
- Repligen Q2 2024 Adj. EPS $0.33, Inline, Sale...
